You are here

Endocrine Therapy after Breast Cancer

Researcher
Annette Stanton at UCLA
Study abstract

The aims of this research are to: (1) through objective and self-report methods, examine rates of adherence in breast cancer patients initiating prescriptions for tamoxifen or aromatase inhibitors (AIs) in a community practice; and (2) examine a theoretically grounded, biopsychological model of predictors of adherence to endocrine therapies in women diagnosed with breast cancer. The model includes both genetic and psychosocial predictors of adherence.

Study review

In an effort to find the best way to help medical personnel and women diagnosed with breast cancer, researchers at the University of California, Los Angeles, have developed an online survey to understand women’s thoughts, feelings, and behaviors relevant to taking endocrine therapies. The researchers wanted to enroll at least 500 volunteers. The Call to Action for this study was sent to Army of Women members on January 11, 2012. The researchers were able to close enrollment on January 23, 2012, after the Army of Women provided them with 2,483 women who were interested in enrolling in the study.